Biomarin Pharmaceutical advertising spend, FY2025
Biomarin Pharmaceutical (BMRN) reported $50.5M of advertising expense for the fiscal year ended Dec 31, 2025. That is 1.6% of revenue of $3.2B. Up 46.4% from FY2024.
Key facts
- Ad spend is 1.7x its FY2020 level ($29.3M), in line with revenue (1.7x).
- FY2025 is the highest year on file, going back to FY2020.
- Largest increase +46.4% in FY2025; largest cut -16.6% in FY2022.
- Ad spend has risen 3 years in a row.
- Ad spend is 1.6% of revenue, about the same as 1.6% in FY2020.
- Biomarin Pharmaceutical spends more on advertising than 1% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.6%.
Ad spend by fiscal year
Ad spend as % of revenue
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.5M | +46.4% | $3.2B | 1.6% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $34.5M | +24.1% | $2.9B | 1.2% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $27.8M | +10.3% | $2.4B | 1.1% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2022 | Dec 31, 2022 | $25.2M | -16.6% | $2.1B | 1.2% | AdvertisingExpense | 10-K Feb 24, 2025 |
| FY2021 | Dec 31, 2021 | $30.2M | +3.1% | $1.8B | 1.6% | AdvertisingExpense | 10-K Feb 26, 2024 |
| FY2020 | Dec 31, 2020 | $29.3M | n/a | $1.9B | 1.6% | AdvertisingExpense | 10-K Feb 27, 2023 |
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Biomarin Pharmaceutical in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 450 | Exelixis | $51.7M | 2.2% | +18.9% | FY2026 |
| 451 | Lindblad Expeditions | $51.7M | 6.7% | +31.2% | FY2025 |
| 452 | ThredUp | $51.1M | 16.4% | +23.1% | FY2025 |
| 453 | Dolby Laboratories | $51M | 3.8% | -11.0% | FY2025 |
| 454 | OppFi | $50.9M | 13.4% | +3.4% | FY2025 |
| 455 | Biomarin Pharmaceutical | $50.5M | 1.6% | +46.4% | FY2025 |
| 456 | Agilent Technologies | $50M | 0.7% | +2.0% | FY2025 |
Full ranking of 458 companies · Biggest increases #38 · New $50M spenders #21
Questions
How much does Biomarin Pharmaceutical spend on advertising?
Biomarin Pharmaceutical spent $50.5M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 26, 2026.
What percentage of revenue does Biomarin Pharmaceutical spend on advertising?
1.6% of revenue in fiscal 2025 ($50.5M of $3.2B). The median across the 458 companies tracked is 4.6%.
Is Biomarin Pharmaceutical spending more on advertising?
Yes. Ad spend rose 46.4% in fiscal 2025 from fiscal 2024. It has risen 3 years in a row.
How does Biomarin Pharmaceutical rank by advertising spend?
#455 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
What does Biomarin Pharmaceutical's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Source
- Filing
- 10-K for FY2025, filed Feb 26, 2026
- Accession number
0001048477-26-000004- Company
- BIOMARIN PHARMACEUTICAL INC, CIK 1048477, SIC 2834 (Pharmaceutical Preparations)
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 4, 2026. Methodology.
- Cite
- Biomarin Pharmaceutical advertising spend, FY2020-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 26, 2026), retrieved Nov 4, 2026. https://io.trudov.com/company/biomarin-pharmaceutical/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies